Novartis India Limited share price
NSE: NOVARTIND · ISIN INE234A01025
Key numbers
- Market cap
- ₹ 4,853 Cr
- Current price
- ₹ 1,965.60
- 52-week high / low
- ₹ 2,589 / 672
- Stock P/E
- 49.6
- Book value
- ₹ 331.3
- Dividend yield
- 0.00%
- ROCE
- 16.3%
- ROE
- 11.6%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- -1.4%
- Profit growth (3 yrs)
- -3.4%
- 1-year return
- 179.6%
About Novartis India Limited
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 84 | 88 | 86 | 91 | 104 |
| Operating profit | 24 | 27 | 22 | 21 | 35 |
| Net profit | 29 | 28 | 16 | 25 | 32 |
| EPS (₹) | - | 11.19 | 6.52 | 10.23 | 13.05 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.